About Us
Rapid Antimicrobial Susceptibility Testing (AST)
Astratus is modernising antimicrobial susceptibility testing for veterinary, research and hospital laboratories
Our Vision
To be one of the world’s leading providers of rapid antimicrobial susceptibility testing and antimicrobial resistance surveillance tools
Our Mission
To accelerate personalised antimicrobial prescribing
through the power of rapid antimicrobial susceptibility testing to help reduce the global burden of antimicrobial resistance in humans and animals
Our Technology
The unique, patented properties of our microcapillaries enables rapid, high throughput antimicrobial susceptibility testing
mcAST optically measures antimicrobial susceptibility
mcAST is as accurate as current methods
unique IP 12+ years in development
10 publications since 2011
Timeline
Founding Team
-
Dr Oliver Hancox
Chief Executive Officer
7 years in Research and Development and both commercial and academic method optimisation.
-
Dr Alexander Edwards
Chief Technical Officer
20+ years in biomedical engineering including 12 years in diagnostics Research and Development.
-
Dr Sarah Needs
Chief Scientific Officer
10+ years of Biochemical Research and Development and validation of novel diagnostics assays.
-
Julie Hart
Chief Medical Officer
30+ years of commercial experience in diagnostics and life sciences, 10 years in NHS pathway transformation.